Fig. 4

Cardiovascular toxicities of cancer therapies. Cardiovascular toxicities of a wide spectrum of cancer therapies can affect the heart (center, left, and right of figure) or peripheral vasculature (bottom row of figure). Ab, antibody; CDK, cyclin dependent kinase; HER2, human epidermal growth factor receptor 2; ICI, immune checkpoint inhibitor; MT, microtubule; PI, platinum inhibitor; TKI, tyrosine kinase inhibitor; Tx, Therapy. Used with permission; from Brown [23], Creative Commons Attribution License [CC BY]